Cargando…

Can molecular stratification improve the treatment of inflammatory bowel disease?

Inflammatory bowel disease (IBD) is a debilitating chronic inflammatory disease of the gastrointestinal (GI) tract. It affects more than 3.5 million people in the western world and places a huge financial burden on healthcare systems. IBD is highly heterogeneous; disease severity and outcomes in IBD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Claire, Baer, Hannah M., Gaya, Daniel R., Nibbs, Robert J.B., Milling, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902263/ https://www.ncbi.nlm.nih.gov/pubmed/31491469 http://dx.doi.org/10.1016/j.phrs.2019.104442

Ejemplares similares

The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease
por: Wright, Pamela B., et al.
Publicado: (2021)

Dietary Strategies for Maintenance of Clinical Remission in Inflammatory Bowel Diseases: Are We There Yet?
por: Gkikas, Konstantinos, et al.
Publicado: (2020)

Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease
por: Moustafa, Ahmed, et al.
Publicado: (2018)

Improving the quality of care for inflammatory bowel disease
por: Ye, Byong Duk, et al.
Publicado: (2019)

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK: The REVIVE study
por: Cummings, Fraser, et al.
Publicado: (2019)

Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease
por: Steell, Lewis, et al.
Publicado: (2021)

Microbial signatures in post-infectious irritable bowel syndrome – toward patient stratification for improved diagnostics and treatment
por: Jalanka, Jonna, et al.
Publicado: (2015)

Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project
por: Fofaria, Rishi K, et al.
Publicado: (2019)

A166 RISK STRATIFICATION OF EARLY RE-HOSPITALIZATION IN PERSONS WITH INFLAMMATORY BOWEL DISEASES USING MULTIVARIABLE MODELS
por: Dziegielewski, C, et al.
Publicado: (2023)

Endoscopic molecular imaging in inflammatory bowel disease
por: Ham, Nam Seok, et al.
Publicado: (2021)

Can we change the natural course of inflammatory bowel disease?
por: Le Berre, Catherine, et al.
Publicado: (2023)

Systematic Review: Components of a Comprehensive Geriatric Assessment in Inflammatory Bowel Disease—A Potentially Promising but Often Neglected Risk Stratification
por: Asscher, Vera E R, et al.
Publicado: (2019)

Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease
por: Vaidy, Katherine, et al.
Publicado: (2020)

Specific T-Cell Subsets Can Predict the Efficacy of Anti-TNF Treatment in Inflammatory Bowel Diseases
por: Dulic, Sonja, et al.
Publicado: (2020)

Benefits of Structured Pediatric to Adult Transition in Inflammatory Bowel Disease: The TRANSIT Observational Study
por: McCartney, Sara, et al.
Publicado: (2022)

A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS
por: Gu, Siyu, et al.
Publicado: (2021)

Novel treatments for inflammatory bowel disease
por: Lee, Hyo Sun, et al.
Publicado: (2018)

Emerging treatments for inflammatory bowel disease
por: Hazel, Karl, et al.
Publicado: (2020)

Food as Treatment of Inflammatory Bowel Diseases
por: Maldonado-Contreras, Ana
Publicado: (2022)

Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics
por: Katsanos, Konstantinos H., et al.
Publicado: (2017)

Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2021)

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
por: Lu, Quan, et al.
Publicado: (2022)

The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease
por: Alghoul, Zahra, et al.
Publicado: (2022)

Molecular Basis of Intestinal Fibrosis in Inflammatory Bowel Disease
por: Andoh, Akira, et al.
Publicado: (2022)

Solving the Puzzle: Molecular Research in Inflammatory Bowel Diseases
por: Krug, Susanne M.
Publicado: (2023)

Can COVID-19 Trigger De Novo Inflammatory Bowel Disease?
por: Taxonera, Carlos, et al.
Publicado: (2021)

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
por: Luber, Raphael P., et al.
Publicado: (2019)

Can vitamin D induce remission in patients with inflammatory bowel disease?
por: Goulart, Ricardo de Alvares, et al.
Publicado: (2022)

Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing
por: Eccles, Jessica Anne, et al.
Publicado: (2020)

Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease
por: Lak, Nathalie S.M., et al.
Publicado: (2021)

Patients with inflammatory bowel disease have higher abdominal adiposity and less skeletal mass than healthy controls
por: Barroso, Teresa, et al.
Publicado: (2018)

Inflammatory bowel disease clinical service recovery during the COVID-19 pandemic
por: Din, Shahida, et al.
Publicado: (2021)

Improving immunization strategies in patients with inflammatory bowel disease
por: Farshidpour, Maham, et al.
Publicado: (2019)

The Potential of Natural Oils to Improve Inflammatory Bowel Disease
por: Zhou, Yaxi, et al.
Publicado: (2023)

Exacerbation of inflammatory bowel disease with isotretinoin
por: Bharmal, Rabaab, et al.
Publicado: (2010)

Inflammatory Bowel Disease: Are Symptoms and Diet Linked?
por: Morton, Hannah, et al.
Publicado: (2020)

Inflammatory bowel disease: can omega-3 fatty acids really help?
por: Barbalho, Sandra Maria, et al.
Publicado: (2016)

Recipe for IBD: can we use food to control inflammatory bowel disease?
por: Witkowski, Mario, et al.
Publicado: (2017)

Can Statin Prevent the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Disease?
por: Jang, Hyun Joo
Publicado: (2019)

miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease
por: Xiao, Xiangjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_78d1o6jdddj29jjcik9nr4l6n7